BeStock  
Stocks › URGN

UroGen Pharma Ltd URGN

US equityMarket cap rank #2742
$42.78 +$1.38 (+3.33%)
Pre-market · Oct 6, 4:10 am ET · After hours $42.78 0.00%
Open$41.38
Prev close$41.40
Day range$40.50 – $42.91
Volume1.28M
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.0%-1.20 pts vs. prior quarter
Institutions holding225+1 vs. prior quarter
Insider trades (recent)32 buys / 18 sellsNet buying
Short interest12.78% of floatDays to cover 9.2 · as of 15 Sep 2026
Short-sale volume share17.3%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%23%30%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.60M (5 inflow days, 15 outflow days).

The five largest holders on file together own 33.0% of shares outstanding.

Largest holders

  • RTW Investments, LP9.30%
  • The Toronto-Dominion Bank6.90%
  • BlackRock6.55%
  • Morgan Stanley5.24%
  • Kynam Capital Management, LP4.98%
  • Jefferies Financial Group Inc.4.50%
  • SG Americas Securities, LLC4.20%
  • American Century Investment Management3.45%

By investor type

  • Hedge Fund32.05%
  • Mutual Fund29.70%
  • Public Company19.53%
  • VC/PE Fund9.19%
  • Private Company4.42%
  • Individual/Insider1.90%
  • Government Pension Fund1.08%
  • Insurance Company0.03%

Reported short interest has held roughly steady near 12.78% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 6,247,498 12.8% 9.2
31 Aug 2026 6,245,387 12.8% 6.8
14 Aug 2026 5,120,407 10.5% 4.8
31 Jul 2026 4,589,109 9.4% 6.6
15 Jul 2026 5,689,384 11.7% 6.9
30 Jun 2026 6,218,229 12.8% 9.4

Discussion

No comments yet — be the first to weigh in on URGN.

Leave a comment

Scroll to Top